Renal Dysfunction in Heart Failure with Preserved Ejection Fraction: Insights from the RELAX Trial

BACKGROUND: Patients with heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD) represent a high-risk phenotype. The Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction (RELAX) trial enrol...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Card Fail
Hlavní autoři: Patel, Ravi B., Mehta, Rupal, Redfield, Margaret M., Borlaug, Barry A., Hernandez, Adrian F., Shah, Sanjiv J., Dubin, Ruth F.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078015/
https://ncbi.nlm.nih.gov/pubmed/31931098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2020.01.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky